Nutrient–Immune Interactions in Critical Care: Mechanisms, Evidence, and Clinical Implications

Abstract

Nutrient–immune interactions are pivotal in the management of critically ill patients, influencing outcomes through modulation of immune responses, infection risk, and recovery trajectories. Recent research highlights the complexity of these interactions, underlining the necessity for individualized nutritional strategies in critical care. This review synthesizes current evidence on nutrient–immune crosstalk, examines underlying mechanisms, outlines epidemiological data, and discusses clinical implications, integrating guideline-based recommendations to inform optimal practice for healthcare professionals managing critically ill populations.

Introduction

Critical illness, characterized by systemic inflammation and multisystem dysfunction, places unique demands on the immune system and metabolic reserves. The interplay between nutrition and immune function is increasingly recognized as a determinant of patient outcomes, with malnutrition, micronutrient deficiencies, and altered metabolic states contributing to immune dysregulation and heightened susceptibility to secondary complications. Understanding nutrient–immune interactions in the intensive care unit (ICU) is essential for clinicians seeking to optimize supportive care and improve survival rates.

Epidemiology / Disease Burden

Malnutrition is prevalent among critically ill patients, with estimates suggesting up to 40–50% of ICU admissions exhibit some degree of nutritional compromise. This burden is associated with increased lengths of stay, higher rates of nosocomial infections, and elevated mortality. The prevalence of hospital-acquired infections in malnourished ICU populations is notably higher, underscoring the importance of early identification and intervention. Emerging data from multicenter studies indicate that timely nutritional support is linked to improved outcomes, yet global disparities in critical care resources and protocols persist.

Pathophysiology

The pathophysiology of nutrient–immune interactions in critical care is multifaceted. Critical illness induces a hypercatabolic state, promoting rapid depletion of macro- and micronutrient stores. Protein-energy malnutrition impairs innate and adaptive immune responses, reducing leukocyte proliferation, phagocytic capacity, and cytokine production. Micronutrients such as vitamin D, zinc, selenium, and glutamine modulate immune cell signaling, antioxidant defense, and inflammation resolution. The gut–immune axis, disrupted in critical illness, further complicates immune regulation by altering microbiota and increasing intestinal permeability, leading to systemic inflammatory responses and sepsis risk.

Risk Factors

Risk factors for nutrient-immune dysfunction in the ICU include pre-existing malnutrition, advanced age, comorbidities such as diabetes and chronic kidney disease, prolonged fasting, and the use of certain medications (e.g., corticosteroids and broad-spectrum antibiotics). Additional risk factors include the severity of the acute illness, duration of mechanical ventilation, and gastrointestinal dysfunction, which impairs nutrient absorption and utilization. Recognizing these risk factors enables targeted interventions and risk stratification in critically ill patients.

Clinical Features

Clinical manifestations of nutrient–immune dysregulation range from poor wound healing and increased infection rates to prolonged ventilator dependency and multi-organ dysfunction. Laboratory indicators may include lymphopenia, hypoalbuminemia, and deficiencies in trace elements. Critically ill patients often exhibit impaired barrier immunity, leading to increased translocation of microbial products and systemic inflammation. These features necessitate a high index of suspicion and prompt nutritional assessment in the ICU setting.

Diagnosis

Diagnosis of nutrient–immune imbalance relies on comprehensive nutritional assessment, including anthropometric measurements, biochemical markers (e.g., prealbumin, transferrin, vitamin levels), and functional immune assays. Screening tools such as the NUTRIC (Nutrition Risk in Critically ill) score and Subjective Global Assessment (SGA) are recommended for early identification of at-risk patients. Point-of-care testing for micronutrient status, though not universally available, can guide tailored supplementation strategies.

Treatment & Management

Management of nutrient–immune interactions in critical care involves early initiation of individualized nutritional support, ideally within 24–48 hours of ICU admission. Enteral nutrition is preferred to preserve gut integrity and modulate immune responses, though parenteral nutrition is indicated when enteral routes are not feasible. Protein requirements are elevated in critical illness (1.2–2.0 g/kg/day), and energy needs must be adjusted for metabolic stress. Micronutrient repletion including vitamin D, selenium, zinc, and omega-3 fatty acids is increasingly recognized as a key component of immune modulation. Regular reassessment and multidisciplinary collaboration are essential to adapt nutritional strategies to dynamic clinical changes.

Recent Advances / Emerging Therapies

Recent advances include immunonutrition formulas enriched with arginine, omega-3 fatty acids, and nucleotides, which have demonstrated benefits in reducing infectious complications and improving immune markers in select populations. Probiotics and prebiotics are being investigated for their role in restoring gut–immune homeostasis, though robust evidence supporting routine use is pending. Personalized nutrition, guided by metabolic and immune profiling, represents an emerging frontier in critical care, with ongoing research on the effects of energy titration, intermittent feeding, and micronutrient pharmacokinetics.

Guideline Recommendations

Current guidelines from major societies including the Society of Critical Care Medicine (SCCM), American Society for Parenteral and Enteral Nutrition (ASPEN), and the European Society for Clinical Nutrition and Metabolism (ESPEN) advocate for early nutritional risk assessment, prioritization of enteral over parenteral nutrition, and targeted supplementation of specific micronutrients in deficient states. Guidelines emphasize the avoidance of overfeeding, close monitoring of metabolic parameters, and individualized care plans. Integration of immune-modulating nutrients is recommended for selected patients, particularly those with sustained inflammation or high risk of infection.

Conclusion

Nutrient–immune interactions in critical care are complex and clinically significant, influencing patient trajectories through effects on inflammation, infection risk, and recovery. Evidence underscores the importance of early, individualized nutritional support and micronutrient optimization, guided by regular assessment and adherence to consensus guidelines. Ongoing research promises further refinement of immunonutrition approaches, with the goal of enhancing immune competence and improving outcomes for critically ill patients. A multidisciplinary, evidence-based approach remains central to the effective management of nutrient–immune dynamics in the ICU.